Your browser doesn't support javascript.
loading
Retrospective cost-effectiveness of the 23-valent pneumococcal polysaccharide vaccination program in Australia.
Chen, C; Beutels, P; Wood, J; Menzies, R; MacIntyre, C R; McIntyre, P; Newall, A T.
Afiliação
  • Chen C; School of Public Health and Community Medicine, University of New South Wales, Sydney, NSW, Australia. Electronic address: chen.chen@unsw.edu.au.
  • Beutels P; Centre for Health Economics Research and Modelling Infectious Diseases (CHERMID), Vaccine and Infectious Disease Institute, University of Antwerp, Antwerp, Belgium.
  • Wood J; School of Public Health and Community Medicine, University of New South Wales, Sydney, NSW, Australia.
  • Menzies R; School of Public Health and Community Medicine, University of New South Wales, Sydney, NSW, Australia.
  • MacIntyre CR; School of Public Health and Community Medicine, University of New South Wales, Sydney, NSW, Australia.
  • McIntyre P; National Centre for Immunisation Research and Surveillance of Vaccine Preventable Diseases (NCIRS), Kids Research Institute, Children's Hospital at Westmead, NSW, Australia.
  • Newall AT; School of Public Health and Community Medicine, University of New South Wales, Sydney, NSW, Australia.
Vaccine ; 36(42): 6307-6313, 2018 10 08.
Article em En | MEDLINE | ID: mdl-30213457
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Análise Custo-Benefício / Vacinas Pneumocócicas Tipo de estudo: Evaluation_studies / Health_economic_evaluation / Observational_studies / Risk_factors_studies Aspecto: Patient_preference Limite: Aged / Female / Humans / Male País/Região como assunto: Oceania Idioma: En Revista: Vaccine Ano de publicação: 2018 Tipo de documento: Article País de publicação: Holanda
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Análise Custo-Benefício / Vacinas Pneumocócicas Tipo de estudo: Evaluation_studies / Health_economic_evaluation / Observational_studies / Risk_factors_studies Aspecto: Patient_preference Limite: Aged / Female / Humans / Male País/Região como assunto: Oceania Idioma: En Revista: Vaccine Ano de publicação: 2018 Tipo de documento: Article País de publicação: Holanda